Michael Fons

Corporate Officer/Principal at University of Texas Medical Branch

64 year

Health Technology

Consumer Services

Michael Fons active positions

Companies	Position	Start	End
University of Texas Medical Branch	Corporate Officer/Principal	-	-

Companies	Position	Start	End
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	Corporate Officer/Principal	2003-12-31	2003-12-31
INOVIO PHARMACEUTICALS, INC.	Corporate Officer/Principal	2004-05-31	-

International

United States

Operational

Corporate Officer/Principal

Sectoral

Health Technology	3
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
INOVIO PHARMACEUTICALS, INC.	Health Technology

Private companies	1
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	Health Technology

Private companies

Health Technology